Structures by: Pham P. T.
Total: 13
C13H5N3S2
C13H5N3S2
CrystEngComm (2018) 20, 1 128
a=7.8613(10)Å b=24.495(3)Å c=6.1207(8)Å
α=90.00° β=90.00° γ=90.00°
2
C15H7N3S2
CrystEngComm (2018) 20, 1 128
a=5.560(5)Å b=14.516(13)Å c=16.611(15)Å
α=90° β=93.872(16)° γ=90°
3
C31H39N3S2
CrystEngComm (2018) 20, 1 128
a=9.1187(16)Å b=10.6243(18)Å c=16.361(3)Å
α=73.912(3)° β=82.666(3)° γ=70.835(3)°
Abacavir methanol 2.5-solvate
C14H18N6O,2.5(C1H4O1)
Acta Crystallographica Section E (2009) 65, 8 o1937
a=19.857(4)Å b=7.2552(15)Å c=13.735(3)Å
α=90.00° β=98.27(3)° γ=90.00°
3146
C22H16N2O4
Acta Crystallographica Section E (2009) 65, 8 o1806
a=7.4689(12)Å b=16.615(3)Å c=7.3917(12)Å
α=90.00° β=108.824(3)° γ=90.00°
(1<i>E</i>,3<i>E</i>,5<i>E</i>,7<i>E</i>)-4,4'-(Octa-1,3,5,7-tetraene-1,8-diyl)dipyridine
C18H16N2
Acta Crystallographica Section E (2010) 66, 3 o508
a=5.5565(12)Å b=17.950(4)Å c=21.542(5)Å
α=90.00° β=94.809(5)° γ=90.00°
03157
C12H6Br2S3
Crystal Growth & Design (2014) 14, 3 916
a=7.622(2)Å b=30.003(6)Å c=5.884(1)Å
α=90.00° β=90.00° γ=90.00°
C13H5BrN3S2
C13H5BrN3S2
Crystal Growth & Design (2014) 14, 3 916
a=9.1417(7)Å b=12.9641(10)Å c=10.8000(9)Å
α=90.00° β=92.378(2)° γ=90.00°
03128
C11H5N3O2S
Crystal Growth & Design (2014) 14, 3 916
a=20.488(10)Å b=5.153(3)Å c=19.516(10)Å
α=90.00° β=91.815(8)° γ=90.00°
03133
C6H4Br2O2S
Crystal Growth & Design (2014) 14, 3 916
a=25.335(4)Å b=5.0261(8)Å c=15.713(2)Å
α=90.00° β=123.924(2)° γ=90.00°
C13H5N3S2
C13H5N3S2
Crystal Growth & Design (2014) 14, 3 916
a=7.8613(10)Å b=24.495(3)Å c=6.1207(8)Å
α=90.00° β=90.00° γ=90.00°
03174
C11H4BrN3O2S
Crystal Growth & Design (2014) 14, 3 916
a=13.677(2)Å b=5.3859(8)Å c=16.245(3)Å
α=90.00° β=93.971(3)° γ=90.00°
03169
C12H8Br2O4S2
Crystal Growth & Design (2014) 14, 3 916
a=19.311(3)Å b=5.1730(8)Å c=15.885(3)Å
α=90.00° β=120.464(2)° γ=90.00°